Management and Prevention of Pre-Eclampsia in Nigeria

Author:

Adeyeye Oluwabunmi Victoria12,Ebubechukwu Nwikwu Vivian13,Olanrewaju Omotayo Faith13ORCID,Eniayewun Aderayo Grace12,Nwuta Chidinma12,Effiong Fortune Benjamin145,Unim Brigid6ORCID

Affiliation:

1. Directorate of Research, TORASIF, Calabar 540004, Nigeria

2. Department of Medicine and Surgery, University of Ibadan, Ibadan 200005, Nigeria

3. Faculty of Pharmaceutical Sciences, University of Nigeria Nsukka, Nsukka 410001, Nigeria

4. Faculty of Medical Laboratory Science, University of Calabar, Calabar 540004, Nigeria

5. African Community for Systematic Reviews and Meta-Analyses (ACSRM), Kigali 4285, Rwanda

6. Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Via Giano della Bella 34, 00162 Rome, Italy

Abstract

This research paper analyses the management and prevention of pre-eclampsia in Nigeria. Although efforts have been made to reduce outcomes due to pre-eclampsia, it still rears its head in the form of high maternal and perinatal morbidity and mortality. The aim of this review was to identify the main obstacles, gaps, and interventions related to the prevention and management of pre-eclampsia in order to be fully knowledgeable of the magnitude of the issue at the national level, to assess if current government policies are adequate and to recommend solutions. A search was performed on online databases and it was completed with hand searches related to the subject matter. Screening tests for early detection of pre-eclampsia are hardly available in Nigeria as many hospitals rely on the history of previous and current pregnancies, blood pressure monitoring and urinalysis–proteinuria. The administration of low-dose aspirin, antihypertensive drugs and magnesium sulphate, coupled with calcium in calcium deficit regions, was recommended. The main barriers to the wider implementation of these strategies are inadequacy of the antenatal care services in providing appropriate care, lack of resources and trained personnel, high healthcare costs, and low antennal care attendance. Improving education and awareness, use of low-cost screening modalities and low-dose aspirin can be deployed in developing countries to curb pre-eclampsia.

Publisher

MDPI AG

Subject

Health Information Management,Health Informatics,Health Policy,Leadership and Management

Reference48 articles.

1. Dulay, A.T. (2022, September 13). Main Line Health System: Pre-eclampsia and Eclampsia. New Jersey: MSD Manual, Professional Version, 2020. Available online: https://www.msdmanuals.com/professional/gynecology-and-obstetrics/abnormalities-of-pregnancy/preeclampsia-and-eclampsia.

2. WHO (2005). The World Health Report 2005: Make Every Mother and Child Count.

3. Arterial hypertension: Epidemiological aspects and risk factors on pregnant and delivered woman;Kimbally;Dakar Med.,2007

4. Pre-eclampsia: Epidemiology and outcome of 995 cases;Mahaba;J. Egypt. Public Health Assoc.,2001

5. Maternal and fetal prognosis of hypertension and pregnancy in Africa (Senegal);Thiam;J. Gynecol. Obstet. Biol. Reprod.,2003

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3